IDR 94.0
(-4.04%)
Breakdown | 2022 | 2021 | 2020 |
---|---|---|---|
Operating Cash Flow | - | - | - |
Net Income | - | - | - |
Depreciation & Amortization | - | - | - |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | - | - | - |
Other non-cash items | - | - | - |
Investing Cash Flow | -6.89 Billion | -23.89 Billion | -1.26 Billion |
Investments in PPE | -6.89 Billion | -25.95 Billion | -1.56 Billion |
Acquisitions | - | - | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | - | - | - |
Financing Cash Flow | 9.12 Billion | 17.62 Billion | 13.54 Billion |
Debt repayment | -4.75 Billion | -24.69 Billion | -3.54 Billion |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 6.5 Billion | 42.5 Billion | 10 Billion |
Other Financing Activities | -2.12 Billion | - | - |
Accounts receivables | - | - | - |
Accounts payables | - | - | - |
Inventory | - | - | - |
Other working capital | - | - | - |
Cash at beginning of period | 4.09 Billion | 78.63 Million | 255.2 Million |
Cash at end of period | 18.56 Billion | 4.09 Billion | 78.63 Million |
Capital Expenditure | -6.89 Billion | -25.95 Billion | -1.56 Billion |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 14.46 Billion | 4.01 Billion | -176.56 Million |
Free Cash Flow | -6.89 Billion | -25.95 Billion | -1.56 Billion |
Breakdown | 2022 FY | 2021 FY | 2020 FY |
---|---|---|---|
Operating Cash Flow | - | - | - |
Net Income | - | - | - |
Depreciation & Amortization | - | - | - |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | - | - | - |
Other non-cash items | - | - | - |
Investing Cash Flow | -6.89 Billion | -23.89 Billion | -1.26 Billion |
Investments in PPE | -6.89 Billion | -25.95 Billion | -1.56 Billion |
Acquisitions | - | - | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | - | - | - |
Financing Cash Flow | 9.12 Billion | 17.62 Billion | 13.54 Billion |
Debt repayment | -4.75 Billion | -24.69 Billion | -3.54 Billion |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 6.5 Billion | 42.5 Billion | 10 Billion |
Other Financing Activities | - | - | - |
Accounts receivables | - | - | - |
Accounts payables | - | - | - |
Inventory | - | - | - |
Other working capital | - | - | - |
Cash at beginning of period | 4.09 Billion | 78.63 Million | 255.2 Million |
Cash at end of period | 18.56 Billion | 4.09 Billion | 78.63 Million |
Capital Expenditure | -6.89 Billion | -25.95 Billion | -1.56 Billion |
Effect of forex changes on cash | - | - | - |
Net cash flow / Change in cash | 14.46 Billion | 4.01 Billion | -176.56 Million |
Free Cash Flow | -6.89 Billion | -25.95 Billion | -1.56 Billion |
HGH
EXLA
MAB1
SOC
ALPM
KPL